Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson’s disease

A microsphere–gel in situ forming implant (MS–Gel ISFI) dual-controlled drug delivery system was applied to a high water-soluble small-molecule compound Rasagiline mesylate (RM) for effective treatment of Parkinson’s disease. This injectable complex depot system combined an in situ phase transition...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Ying, Zhang, Xuemei, Mu, Hongjie, Hua, Hongchen, Duan, Dongyu, Yan, Xiuju, Wang, Yiyun, Meng, Qingqing, Lu, Xiaoyan, Wang, Aiping, Liu, Wanhui, Li, Youxin, Sun, Kaoxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058670/
https://www.ncbi.nlm.nih.gov/pubmed/29275639
http://dx.doi.org/10.1080/10717544.2017.1419514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058670/
https://www.ncbi.nlm.nih.gov/pubmed/29275639
http://dx.doi.org/10.1080/10717544.2017.1419514

Ejemplares similares